World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
112
Citations
74948
World Ranking
5048
National Ranking
2734

Overview

Talmadge E. King is affiliated with the University of California, San Francisco in the United States. Their research focuses primarily on topics related to smoking behavior and cessation, contributing to the broader field of medicine with a specialization in physiology.

Their body of published work includes contributions to the American Journal of Respiratory and Critical Care Medicine. One notable paper is titled E-Cigarette or Vaping Product Use-associated Lung Injury: Developing a Research Agenda. An NIH Workshop Report, published in 2020 within the same journal. This publication has been cited multiple times and addresses the emerging health issues related to vaping and lung injury, indicating engagement with current respiratory health challenges.

  • Smoking Behavior and Cessation

Frequent collaborators in their research include Laura E. Crotty Alexander, Lorraine B. Ware, Carolyn S. Calfee, Sean J. Callahan, and Thomas Eissenberg, reflecting a network of colleagues who participate in pulmonary and critical care research topics.

  • Laura E. Crotty Alexander
  • Lorraine B. Ware
  • Carolyn S. Calfee
  • Sean J. Callahan
  • Thomas Eissenberg

Their scientific contributions predominantly engage with the subfield of physiology, emphasizing the biological mechanisms involved in respiratory health and disease. The focus on medicine underscores their involvement in clinical and translational research areas aimed at understanding and addressing lung conditions.

  • Medicine

  • Physiology

The combination of their areas of study and collaborative network points to a concentrated effort within pulmonary and critical care medicine, addressing both behavioral factors such as smoking and physiological impacts on lung function. Their work contributes to shaping research agendas in response to emerging health threats related to vaping product use.

Best Publications

  • An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-Based Guidelines for Diagnosis and Management

    Ganesh Raghu;Harold R. Collard;Jim J. Egan;Fernando J. Martinez

  • American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias

    William D. Travis;Talmadge E. King;Eric D. Bateman;David A. Lynch

  • An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias

    William D. Travis;Ulrich Costabel;David M. Hansell;Talmadge E. King

  • A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis

    Talmadge E. King;Williamson Z. Bradford;Socorro Castro-Bernardini;Elizabeth A. Fagan

  • Idiopathic pulmonary fibrosis

    Talmadge E King;Annie Pardo;Moisés Selman

  • Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.

    Paul W Noble;Carlo Albera;Williamson Z Bradford;Ulrich Costabel

  • Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy.

    Moisés Selman;Talmadge E. King;Annie Pardo

  • Clinical course and prediction of survival in idiopathic pulmonary fibrosis.

    Brett Ley;Harold R. Collard;Talmadge E. King

  • Prednisone, Azathioprine, and N-Acetylcysteine for Pulmonary Fibrosis

    Ganesh Raghu;Kevin J Anstrom;Talmadge E King;Joseph A Lasky

  • Acute Exacerbations of Idiopathic Pulmonary Fibrosis

    Harold R. Collard;Bethany B. Moore;Kevin R. Flaherty;Kevin K. Brown

  • A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis

    Brett Ley;Christopher J. Ryerson;Eric Vittinghoff;Jay H. Ryu

  • Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model.

    Talmadge E. King;Janet A. Tooze;Marvin I. Schwarz;Kevin R. Brown

  • BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis

    Talmadge E. King;Jürgen Behr;Kevin K. Brown;Roland M. du Bois

  • Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis.

    Harold R. Collard;Talmadge E. King;Becki Bucher Bartelson;Jason S. Vourlekis

  • A Placebo-Controlled Trial of Interferon Gamma-1b in Patients with Idiopathic Pulmonary Fibrosis

    Ganesh Raghu;Kevin K. Brown;Williamson Z. Bradford;Karen Starko

  • Idiopathic pulmonary fibrosis: Relationship between histopathologic features and mortality

    Talmadge E. King;Marvin I. Schwarz;Kevin Brown;Janet A. Tooze

  • Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?

    Kevin R. Flaherty;Talmadge E. King;Ganesh Raghu;Joseph P. Lynch

  • Utility of a Lung Biopsy for the Diagnosis of Idiopathic Pulmonary Fibrosis

    Gary W. Hunninghake;M. Bridget Zimmerman;David A. Schwartz;Talmadge E. King

  • The Clinical Course of Patients with Idiopathic Pulmonary Fibrosis

    Fernando J. Martinez;Sharon Safrin;Derek Weycker;Karen M. Starko

  • Idiopathic nonspecific interstitial pneumonia: Report of an American thoracic society project

    William D. Travis;Gary Hunninghake;Talmadge E. King;David A. Lynch

Frequent Co-Authors

Harold R. Collard
Harold R. Collard University of California, San Francisco
Paul W. Noble
Paul W. Noble Cedars-Sinai Medical Center
Roland M. du Bois
Roland M. du Bois Imperial College London
Ulrich Costabel
Ulrich Costabel University of Duisburg-Essen
Dominique Valeyre
Dominique Valeyre Université Paris Cité
Kevin K. Brown
Kevin K. Brown National Jewish Health
Ganesh Raghu
Ganesh Raghu University of Washington
Steven A. Sahn
Steven A. Sahn Medical University of South Carolina
Paul J. Wolters
Paul J. Wolters University of California, San Francisco
Fernando J. Martinez
Fernando J. Martinez University of Massachusetts Chan Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA opens many alternative and complementary avenues for healthcare professionals through online education. Flexible pathways now offer students and working professionals opportunities to specialize or upskill without putting their careers on hold.

Those interested in allied health fields may consider a nutrition degree online, which can lead to roles in clinical nutrition, wellness coaching, or public health advocacy. For those looking to move into healthcare administration or leadership roles, cahme accredited online mha programs ensure recognized, high-quality training in healthcare management.

Registered nurses can find increased career mobility and earning potential through online rn-bsn programs without clinicals, ideal for professionals balancing work and study. Advanced practice nurses seeking the peak of clinical education may pursue the fastest msn to dnp program, which accelerates the path to doctoral-level qualifications.

Each of these online options provides flexibility, accessibility, and specialized focus, supporting diverse career pathways within the healthcare sector.

Best Scientists Citing Talmadge E. King

Trending Scientists

Recently Published Articles